Scientists find new biomarker to guide cancer immunotherapy – Reuters
Express.co.uk |
Scientists find new biomarker to guide cancer immunotherapy
Reuters The current widely used benchmark when giving cancer immunotherapy is a protein called PDL-1. However, many experts view PDL-1 as a "blunt instrument", since it does not match precisely to drug response, leading to the consideration of other measures, … Lung cancer cure – deaths could be reduced following THIS treatment breakthrough |
